@article{bf5af1d5492c42e5bdfd45ad0ae0f47c,
title = "Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction",
abstract = "Antigen-specific immunotolerance limits the expansion of self-reactive T cells involved in autoimmune diseases. Here, we show that the E3 ubiquitin ligase Cbl-b is upregulated in T cells after tolerizing signals. Loss of Cbl-b in mice results in impaired induction of T cell tolerance both in vitro and in vivo. Importantly, rechallenge of Cbl-b mutant mice with the tolerizing antigen results in massive lethality. Moreover, ablation of Cbl-b resulted in exacerbated autoimmunity. Mechanistically, loss of Cbl-b rescues reduced calcium mobilization of anergic T cells, which was attributed to Cbl-b-mediated regulation of PLCγ-1 phosphorylation. Our results show a critical role for Cbl-b in the regulation of peripheral tolerance and anergy of T cells.",
author = "Jeon, {Myung Shin} and Alex Atfield and K. Venuprasad and Connie Krawczyk and Renu Sarao and Chris Elly and Chun Yang and Sudha Arya and Kurt Bachmaier and Leon Su and Dennis Bouchard and Russel Jones and Mathew Gronski and Pamela Ohashi and Teiji Wada and Debra Bloom and Fathman, {C. Garrison} and Liu, {Yun Cai} and Penninger, {Josef M.}",
note = "Funding Information: We thank A. Altman, K. Sugie, H. Tabata, Y. Tanaka, and other colleagues at the Division of Cell Biology for support and discussions; K. Hu for technical assistance; M. Naramura and H. Gu for Cbl-b −/− mice and suggestions; T. Watts and P. Liu for helpful discussions; and F-F. Liu for kind help. A.A. is supported by a University of Toronto open fellowship. This work is supported by grants to Y.-C.L. from the National Institutes of Health (grants RO1AI50280 and RO156558) and a biomedical research grant from the Arthritis Foundation and by grants to J.M.P. from the Canadian Institute of Health Research (CIHR), Euro-Thymaide (6. EU framework), the National Bank of Austria, and the Austrian Academy of Science. J.M.P. holds equity in a company that attempts to make cbl-b inhibitors.",
year = "2004",
month = aug,
doi = "10.1016/j.immuni.2004.07.013",
language = "English (US)",
volume = "21",
pages = "167--177",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "2",
}